Authors
Weaam Ebrahim, Amal Hassan Aly, Victor Wray, Attila Mándi, Marie Hélène Teiten, François Gaascht, Barbora Orlikova, Matthias U Kassack, Wenhan Lin, Marc Diederich, Tibor Kurtan, Abdessamad Debbab, Peter Proksch
Publication date
2013
Journal
Journal of Medicinal Chemistry
Volume
56
Issue
7
Pages
2991–2999
Publisher
American Chemical Society
Description
Two new metabolites, embellicines A and B (1 and 2), were isolated from the EtOAc extract of the fungus Embellisia eureka, an endophyte of the Moroccan plant Cladanthus arabicus (Asteraceae). The structures of these new compounds were determined on the basis of extensive one- and two-dimensional NMR spectroscopy as well as by high-resolution mass spectrometry. The absolute configuration of embellicine A (1) was determined by TDDFT ECD calculations of solution conformers, whereas that of embellicine B (2) was deduced based on ROESY correlations and on biogenetic considerations in comparison to 1. Both embellicines (1 and 2) are cytostatic, cytotoxic, and inhibit NF-κB transcriptional activity, indicating that inhibition of NF-κB may be a possible mechanism of action of these compounds. Embellicine B (2) was the most active compound encountered in this study and acts at nanomolar …
Total citations
20132014201520162017201820192020202120222023202444543583244
Scholar articles
W Ebrahim, AH Aly, V Wray, A Mándi, MH Teiten… - Journal of medicinal chemistry, 2013